Meet the team

As I have grown older, and a bit wiser, I feel most passionate about solving the big problems with wide impact. One that lies close to my areas of ability is the challenge of more equitable access to pathology services, as a key to quality health for the world’s population. Far too many areas of the world are stymied by the total absence of pathologists, and even more are hampered by inadequately trained pathologists. I believe the tools we now have in digital pathology and remote learning enable us to solve this problem, and that doing so will change the outcome for millions of patients, particularly those from developing areas of the world, who will develop cancers, heart disease, diabetes, or other disorders that will otherwise disrupt families, careers, and shorten life. I believe we can make a difference in this story and am devoting my talents to do so.

AP/CP and Cytopathology boarded pathologist at the Orlando VAMC

Dr. Razzano is an AP/CP and Cytopathology boarded pathologist working at the Orlando VAMC. She was named by The Pathologist’s Power List in 2018 as one of “100 of the best, brightest, and most powerful advocates of pathology” and was recognized again on the 2019 Power List as one of “100 of the industry’s top trailblazers”. She was also awarded the American Society of Clinical Pathology’s 2018 Top 5, 40 under Forty distinction for “achievements and leadership qualities that are making an impact on pathology and laboratory medicine.” Her career goals are to contribute solutions to the challenges faced by low resource laboratories nationally and internationally.

Dr. Chhavi Chauhan is a biomedical researcher, expert scholarly communicator, and a sought-after mentor in the fields of scientific research, scholarly publishing, and AI Ethics, especially for women and minorities. She is a thought leader, a renowned international speaker, and a strong advocate for equitable and accessible healthcare and is an invited/elected Board member for The Israeli Association for Ethics in Artificial Intelligence Scientific Council, Society for Scholarly Publishing, the Open Pathology Education Network, Digital Pathology Association (DPA), the Digital Pathology Association Foundation, Women in AI Ethics, SteamBloom, & Jain Study Center of North Carolina. She sits at the intersection of scientific research, scholarly communications, science policy, medical education, and responsible tech in healthcare. Her vision is to provide equitable personalized healthcare to all, beyond geographies, and despite socioeconomic disparities. She is passionate about mentoring.

She was named in the AI Makers 150 AI & Analytics Leaders & Influencers 2021 List, The 100 Brilliant Women in AI Ethics 2022 list, the Top 100 Women of the Future 2023 List, and was listed as a Finalist for the AI in Researcher Award ’23 from Women In AI. She co-authors a newsletter on “Augmenting Scholarly Publishing: Intelligent Tools & Trends.

Dr. Kamran Mirza is the Godfrey D. Stobbe Professor of Pathology Education, Clinical Professor of Pathology, Assistant Chair of Education and Director of the Division of Education Programs at the University of Michigan (Michigan Medicine) in Ann Arbor, MI.

Dr. Mirza completed medical school at the prestigious, independent, research University – Aga Khan University in Karachi, Pakistan in 2003. He completed his Ph.D. at the University of Illinois at Chicago in 2010. He continued his training at the University of Chicago, where he completed an AP /CP Pathology residency and received fellowship training in hematopathology and thoracic pathology. Given his passion for medical education, he completed a fellowship in Medical Education Research, Innovation, Teaching & Scholarship (MERITS) at the University of Chicago.

Dr. Mirza spearheaded the creation of PathElective.com, a free, modular website that has provided pathology education to over 100,000 users across the world in the past year alone. In efforts of advancing pathology, he has also co-founded the ASCP’s Virtual Pathology Grand Rounds, the PathPod podcast, the International Collaborative of Pathologists, www.hemereports.com, and the Digital Communications Fellowship in Pathology in partnership with the Pathologist magazine.

Dr. Mirza’s educational research focuses on molecular pathogenesis of myeloid malignancies, novel pedagogical tools in medical education, the advancement of interprofessional education, and use of social media for pathology education. He is passionate about pathology education and training and making such education widely and freely available around the world.

Dr. Gonzalez is Professor of Pathology and Laboratory Medicine, Medical Director of Digital Pathology, and Director of Gastrointestinal Pathology at Emory University Hospital. He received his MD from the Medical College of Georgia and completed AP/CP residency training at Emory University, followed by fellowships in surgical and gastrointestinal pathology at Vanderbilt University.

Dr. Gonzalez has authored more than 150 peer-reviewed publications and a textbook on liver pathology, as well as chapters for several other textbooks and numerous topics on Pathology Outlines, where he previously served as Editor in Chief. He has lectured nationally and internationally, including at USCAP and CAP annual meetings, and has given several lectures on the pathCast platform. He has served as Chair of the CAP Surgical Pathology Committee (term ending 2026) and has participated in multiple dataset authoring committees for the International Collaboration on Cancer Reporting. He is currently President-Elect of the Rodger C. Haggitt Gastrointestinal Pathology Society, Chair of the Social Media Subcommittee for the International Academy of Pathology, and a Regional Editor for Histopathology. Dr. Gonzalez has received residency teaching awards from Beth Israel Deaconess Medical Center and Emory, and in 2023, he received the Gastrointestinal Pathology Society’s Jack Yardley Investigator Award.

Dr. Tran completed her medical training at Ho Chi Minh City University of Medicine and Pharmacy in Viet Nam, followed by a pathology residency at the University of Oklahoma Health Sciences Center. She then completed two informatics fellowships, with the first one at the Oregon Health & Science University and the second one at the National Cancer Institute. Dr. Tran also completed a hematopathology fellowship at the Oregon Health & Science University and has since been practicing as a hematopathologist at The Permanente Medical Group. She is passionate about global pathology education and training, aiming to improve the quality of cancer care in underserved areas and developing countries.

Allen Pack currently holds the role of Chief Financial Officer at White Cup, Inc. a CRM software company. His 30+ years of financial expertise include strategic modeling, M&A, financial reporting, tax, audit and revenue recognition. Prior to joining White Cup, Allen was the controller at Gaiam (a public company with $300 million in revenue NASDAQ: GAIA), and the Corporate Accounting Director at Lumen – a public telecom company with $12 billion in revenues (NYSE: LUMN). Allen is a CPA and started his career with Arthur Andersen in Silicon Valley, after graduating from Brigham Young University. Allen enjoys backpacking, jazz piano, gardening and spending time with family. LinkedIn

Dr. Adeyi is an anatomic pathologist with expertise in liver and transplantation pathology. His clinical practice covers medical, transplant and oncologic diseases of the liver, with more than 15 years’ experience as a hepatobiliary pathology sub-specialist. His primary research interest is in transplant and tumor immunology. During his career he has combined an active clinical service with research and teaching as well as participating locally, nationally, and internationally as a key resource in medical, transplantation and oncologic liver diseases.

Arun R. Napit, MD, is a medical graduate from Nepal who completed his medical education at Government Medical College, Aurangabad in India. He is currently a pathology resident at the University of Missouri–Kansas City. His interest in pathology began during his clinical rotations in medical school, where he recognized the specialty’s essential role in patient care. He was particularly drawn to its interdisciplinary nature and its pivotal function in diagnosis and prognosis.

Dr. Napit is especially interested in surgical pathology, cytopathology, hematopathology, and molecular pathology. He views joining OPEN as a prestigious opportunity to contribute meaningfully to the organization’s mission while continuing to grow his expertise. Through his involvement, he hopes to help bridge global knowledge gaps in pathology and support the advancement of the field worldwide.

Dr. Bychkov is a Director of Digital Pathology at Kameda Medical Center, Japan. He graduated with an M.D. from Russia where he also completed residency training and practiced in anatomic pathology. Later, he earned a Ph.D. in molecular medicine in Nagasaki, Japan and supervised research projects at Chulalongkorn University, Thailand.

His subspecialty is thyroid pathology, and he has contributed to the 2022 WHO classifications of Endocrine tumors and Hematolymphoid tumors. Additionally, his professional and research interests include digital and computational pathology.

Dr. Bychkov is a co-founding member of the Asian Society of Digital Pathology (2024) and the Asian Thyroid Working Group (2017). He has published extensively and authored more than 120 articles in peer reviewed journals and book chapters. Dr. Bychkov serves as a deputy editor-in-chief for Pathology Outlines and as an academic editor for several international journals. He is also known for his studies on the global pathology workforce, thereby having a wide professional network across all continents.

Dr. Pham Tuan Anh is a medical oncologist at National Cancer Hospital of Viet Nam (K Hospital). He attained his MD in 2009, MSc in 2012 and PhD in 2021 from Ha Noi Medical University. He received 3-year residency training on medical oncology at K Hospital. He also studied at National University Cancer Institute, Singapore in 2011 as a clinical fellow, completed a short clinical attachment at Northern Sydney Cancer Centre in Sydney, Australia in 2012 and undertook clinical training course on medical oncology at Asan Medical Center, Seoul, Korea in 2013 and at National Cancer Center, Tokyo, Japan in 2014. Dr. Tuan Anh is full member of American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO) and Asia Pacific Regional Council of ASCO. His achievements were recognized in 2013 & 2016 when he received IDEA (International Development & Education Award) of ASCO. Dr. Tuan Anh has been the co-investigator on a number of international clinical trials conducted in Viet Nam, especially on lung cancer. He also has served on cancer protocol committees for K Hospital. He has co-authored some books, written many articles in oncology as well. He has a strong desire to improve and innovate cancer care in Viet Nam.

Dr. Singh works at Summit Health as the Director of Dermatopathology and Digital Pathology. He is the founder of PathPresenter, an online digital platform that has 55,000+ users in 180+ countries and is used by multiple academic departments, private pathology groups and organizations in the US and all over the world. (pathpresenter.com) Previously Dr. Singh was a professor of Pathology and Dermatology at Northwell and Icahn School of Medicine at Mt. Sinai.

Some of Dr. Singh’s achievements include the “Lifetime Achievement Award” from the College of American Pathologists (CAP) for creating PathPresenter. He is the recipient of the ‘Teacher of the Year Award’ at Mt. Sinai School of Medicine for 5 consecutive years. He served as the Chair of the American Society of Dermatopathology Informatics Committee, Board Member of DPA, Editorial Board of the WHO for Classification of tumors, 5th Edition. He was nominated on the Pathologist “Power List 100” put out by the Pathologist for 2020, 2021 and 2022.

Dr. Singh Currently serves on the Sulzberger Grant Committee of the AAD, Digital and Computational Pathology Committee of the CAP, Education Committee of DPA, and Computational Pathology Subcommittee of the WHO. He is the creator and Chief Editor of app-mydermpath, which is the most downloaded app of the AAD, and online education resource-Dermatopathology for residents. He is the Chief Editor and Author of print book-Ace the Boards: Dermatopathology and Surgical Pathology Reimagined, available on Amazon. Guest Editor for an upcoming section in the Archives on LLM- a joint venture of the CAP, DPA and API. Lastly, he is a moderator for running DAPA Grand Rounds where he organizes and talks every month online with one renowned faculty who comes and teaches online.

John Memarian is a seasoned healthcare leader with over 20 years of expertise spanning clinical practice, healthcare operations, and innovative technology development. Beginning his career as a physician assistant, he dedicated more than seven years to hands-on care in Invasive Radiology and Surgical Procedures. Transitioning into executive leadership, he has overseen radiology, cardiology, emergency medicine, and outpatient surgery services while driving advancements in biosciences, IT solutions, enterprise imaging, digital pathology, cloud technologies, and clinical genomics.

A recognized innovator, John has successfully introduced groundbreaking technologies to U.S. and global markets, including Thromboelastography (TEG), Vendor Neutral Archives (VNA), DICOM-compliant digital pathology, and point-of-care clinical genomics. His deep understanding of clinical workflows and healthcare interoperability standards enables effective alignment between medical needs and digital health solutions.

John is professionally affiliated with the Digital Pathology Association (DPA), the Society for Imaging Informatics in Medicine (SIIM), the Radiological Society of North America (RSNA), the Association for Medical Imaging Management (AHRA), the Healthcare Information & Management Systems Society (HIMSS), and the American Society of Clinical Oncology (ASCO).

His education & certifications include a Master of Science in Leadership, Strategy & Management, a Bachelor’s degree in business administration, a Technical Degree in Allied Health Technologies, and certifications in Electrodiagnostic Testing, Ultrasound Physics, and Computerized Radiology, and Invasive Cardiology.

John holds volunteer & advisory roles as Board Advisor for Global Newborn Solutions (addressing global infant mortality due to hypothermia), part of the Board of Directors for the Digital Pathology Association (DPA), and is a Member of the DPA Membership Committee

Dr. Xiaoying Liu is an Associate Professor in the Department of Pathology and Laboratory Medicine at Dartmouth-Hitchcock Medical Center (DHMC) and the Geisel School of Medicine at Dartmouth. She serves as Director of Cytopathology, Chair of the Cytopathology Committee of the Clinical Competency Committees (CCC) at DHMC, and Course Director of Pathology Electives at Geisel.

Her national leadership includes Chair of the Chinese American Pathologists Association (CAPA) Education Committee, Co-Chair of the CAPA Cytopathology Subcommittee, and Chair of the CAPA-ASC Companion Meeting Committee. She also serves on the CAPA Executive Committee.

Dr. Liu completed her Anatomic and Clinical Pathology residency and Cytopathology fellowship at the University of Kansas Medical Center. She joined DHMC in 2009 and has since dedicated over 15 years to teaching medical students, residents, fellows in cytology and endocrinology, and delivering cytopathology lectures at local, national, and international forums.

Her research focuses on thyroid and pancreatic cancers, with a growing emphasis on applying machine learning and AI to cytopathology and histology. She has published over 80 peer-reviewed articles and book chapters. Her subspecialties include cytopathology, telecytopathology, fine needle aspiration, and gastrointestinal pathology.

Dr. Deebajah is the Medical Director, Molecular Pathology Artificial Intelligence and Data Science and an Associate Staff in the Section of Molecular Pathology and Cytogenomics in Cleveland Clinic. His goals focus on advancing the field of digital pathology and pathology informatics through innovative research, particularly in developing predictive models for pathology diagnoses and outcomes. Dr. Deebajah aim to enhance the educational landscape in pathology by integrating cutting-edge digital tools and methodologies into academic and clinical training programs. Additionally, Dr. Deebajah is deeply interested in molecular medicine and precision medicine, aiming to leverage these areas to improve diagnostic accuracy and personalized treatment strategies

Dr. Jose Jessurun, MD, is a Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine in New York. An internationally recognized expert in gastrointestinal and liver pathology, he has built a distinguished career spanning more than three decades in academic medicine, clinical practice, and research.

Dr. Jessurun received his medical degree from the National Autonomous University of Mexico and completed advanced training in anatomic and surgical pathology at leading institutions, including Massachusetts General Hospital and a fellowship in gastrointestinal pathology at Johns Hopkins Hospital. Prior to joining Weill Cornell, he held senior faculty and leadership roles at the University of Minnesota, where he served as Director of Surgical Pathology for over a decade.

Dr. Jessurun has authored or co-authored more than 200 peer-reviewed publications and contributed to major pathology textbooks. His work has significantly advanced understanding of gastrointestinal diseases, liver pathology, and transplant-related conditions. In addition to his research, he has delivered over 150 invited lectures worldwide and served on the editorial board of Human Pathology.

Dr. Jessurun is also a dedicated educator and mentor, having trained approximately 150 pathology residents and numerous fellows. He is board-certified in anatomic pathology in both the United States and Mexico and is fluent in Spanish, English, and French. His contributions to medicine have been recognized with numerous honors, including designation as a Castle Connolly “Top Doctor.”

Michael Quick is a seasoned diagnostics executive with nearly 30 years of experience spanning laboratory science, R&D leadership, and commercial strategy. He currently serves as Chief Commercial Officer at Tactus AI, an early-stage company building humanoid robotic lab assistants and intelligent orchestration software for regulated laboratory environments.

Prior to Tactus AI, Michael spent the bulk of his career at Hologic, where he rose to Vice President of Research & Development, driving innovation across the company’s diagnostics portfolio. Mike also led the emerging markets business for Hologic for nearly a decade, expanding access to transformative technologies in Latin America, Middle East, Africa, Eastern Europe, and Southeast Asia. His career began at the microscope — diagnosing cancer as a practicing cytologist — giving him a firsthand understanding of the challenges facing laboratory professionals worldwide.

Michael is Past President of the Digital Pathology Association and holds a biology degree from the University of Vermont. He is a passionate advocate for leveraging technology to empower — not replace — laboratory professionals, a philosophy that animates both his current work in robotics and his commitment to expanding access to pathology education in underserved settings.

Matthew G Hanna, MD is the Vice Chair of Pathology Informatics at the University of Pittsburgh Medical Center (UPMC). Dr Hanna serves on the UPMC Computational Pathology & AI Center of Excellence (CPACE) Director of AI Operations. He is an internationally recognized leader in digital and computational pathology, with a focus on translating digital operations and artificial intelligence into routine clinical practice. Dr Hanna serves on the Executive Board of the Digital Pathology Association. He also actively contributes as a member of the CAP as the Chair of the Artificial Intelligence Committee and member of the Council of Informatics and Pathology Innovation. His clinical interests include breast pathology, informatics, digital pathology, image analysis, machine learning, clinical operations/implementation, and decision support tools.

Dr. Glassy is a community pathologist in Southern California and director of pathology at Providence Little Company of Mary Medical Center, San Pedro. He is a member of Affiliated Pathologists Medical Group, a 40 person independent pathology group covering 15 hospitals and laboratories in California, Portland and Phoenix. Dr. Glassy has won a number of pathology awards, including the Distinguished Service Award, Excellence in Education Award, and Pathologist of the Year Award from the College of American Pathologists (CAP). He served as chairman of the Hematology and Clinical Microscopy, Publications, Digital Pathology, Curriculum, and Information Technology Leadership Committees and the Council on Membership and Professional Development. He is a past Governor of the CAP, board member of the CAP Foundation, and a graduate of the CAP Engaged Leadership Academy. He is past president of the Digital Pathology Association. He edited, wrote and illustrated several pathology color atlases and developed software programs for pathology reporting, outreach, and practice management. He holds a green belt in Six Sigma. He is a former trustee of the American Board of Pathology and currently is co-chair of the ABPath CertLink Anatomic Pathology TDAC. Dr. Glassy received his medical degree from the University of California, San Francisco. He did his pathology residency and hematopathology fellowship at Harbor-UCLA Medical Center.